Carbon Quantum Dots Biosensor: Advanced Detection Technologies And Applications In Biomedical Diagnostics

Fundamental Properties And Structural Characteristics Of Carbon Quantum Dots For Biosensor Applications

Carbon quantum dots are quasi-spherical, zero-dimensional carbon-based nanomaterials with particle sizes ranging from 1.5 to 10 nm, exhibiting discrete quantum confinement effects that generate tunable photoluminescence (PL) across UV to near-infrared wavelengths 1,5. The structural composition of CQDs typically includes a sp²/sp³ hybridized carbon core enriched with surface functional groups such as carboxyl (-COOH), hydroxyl (-OH), carbonyl (C=O), and amine (-NH₂), which are critical for aqueous solubility, biocompatibility, and covalent conjugation with biomolecules 1,3. High-resolution transmission electron microscopy (HR-TEM) analysis reveals that CQDs synthesized from natural precursors like castor leaves exhibit uniform size distributions (average 2.7 nm) with weak crystallinity, while X-ray photoelectron spectroscopy (XPS) confirms elemental compositions of approximately 82.64% carbon, 16.02% oxygen, and 1.33% nitrogen 1. Energy-dispersive X-ray spectroscopy (EDX) further validates the presence of heteroatom doping, which modulates the electronic band structure and enhances fluorescence quantum yields (QY) ranging from 5% to 80% depending on synthesis conditions 5,18.

The optical properties of CQDs are governed by both quantum confinement effects within the carbon core and surface state emissions arising from functional groups and defect sites 3,5. These materials exhibit excitation-dependent multicolor emission, enabling wavelength-tunable fluorescence by adjusting excitation wavelengths—a property exploited in multiplexed biosensing applications 5,10. Compared to traditional semiconductor quantum dots (e.g., CdSe, PbS) and organic fluorophores, CQDs demonstrate superior photostability under continuous UV irradiation, resistance to photobleaching, and negligible cytotoxicity (LD₅₀ values exceeding 1 mg/mL in mammalian cell lines), making them ideal candidates for in vivo bioimaging and long-term biosensor deployment 1,3,18. Boronic acid-functionalized CQDs, synthesized via laser ablation of arylboronic acid solutions, achieve fluorescence quantum yields exceeding 40% while maintaining stability against photobleaching radiation, representing a significant advancement for optical biosensor platforms 3.

Synthesis Methodologies And Precursor Selection For Biosensor-Grade Carbon Quantum Dots

Bottom-Up Hydrothermal And Microwave-Assisted Synthesis Routes

The production of CQDs for biosensor applications predominantly employs bottom-up synthesis strategies, wherein small organic molecules or biomass precursors undergo carbonization to form nanoscale carbon structures 3,5. Hydrothermal synthesis, conducted in high-pressure autoclaves at temperatures between 100–500°C for 2–24 hours, represents the most widely adopted method due to its simplicity, scalability, and compatibility with aqueous media 13,18. For instance, soybean dregs mixed with deionized water at mass ratios of 1:10 to 1:50 and heated at 180–220°C for 6–12 hours yield CQDs with excellent water dispersibility and fluorescence QY of 15–25%, suitable for heavy metal ion detection (Fe³⁺, Hg²⁺) with detection limits as low as 30 nmol/L 13. The reaction mechanism involves dehydration, polymerization, and aromatization of carbohydrate and protein components, followed by nucleation and growth of carbon nanoparticles 13,18.

Microwave-assisted synthesis offers rapid heating rates (reaching 200°C within 5–10 minutes) and uniform energy distribution, enabling one-pot preparation of CQDs from natural precursors such as Ferula asafoetida or Chenopodium album extracts without post-treatment purification 5,18. This approach reduces synthesis time from hours to minutes while maintaining high QY (20–35%) and producing CQDs with average diameters of 3–5 nm 5. The microwave method is particularly advantageous for large-scale production, as it eliminates the need for complex equipment and hazardous solvents, aligning with green chemistry principles 5,18. Solvothermal synthesis using organic solvents (e.g., ethanol, DMF) combined with nitrogen-rich precursors like urea enables heteroatom doping, which red-shifts emission wavelengths and enhances sensitivity to specific analytes—for example, blue inkjet dye and urea reacted at 160°C for 8 hours produce nitrogen-doped CQDs exhibiting UV-responsive color change properties suitable for cumulative UV exposure sensors 4.

Top-Down Approaches And Laser Ablation Techniques

Top-down synthesis methods involve fragmentation of bulk carbon materials (graphite, carbon nanotubes, graphene oxide) into nanoscale CQDs through physical or chemical exfoliation 3. Laser ablation of arylboronic acid solutions using pulsed lasers (wavelength 532 nm, pulse duration 10 ns, energy density 50–100 mJ/cm²) generates boronic acid-functionalized CQDs with controlled size distributions (2–6 nm) and high crystallinity, achieving fluorescence QY above 40% 3. This method allows precise control over surface chemistry by selecting specific aromatic precursors, enabling direct functionalization for biosensor applications without additional conjugation steps 3. Electrochemical oxidation of graphite electrodes in acidic media (0.1 M H₂SO₄, applied potential +2.0 V vs. Ag/AgCl for 2–4 hours) produces carboxyl-rich CQDs with average sizes of 4–7 nm, which can be directly deposited onto electrode surfaces for electrochemical biosensor fabrication 8.

Biosensor Architectures Integrating Carbon Quantum Dots

Electrochemical Biosensors With CQD-Modified Electrodes

Electrochemical biosensors leverage the excellent electrical conductivity and large surface area of CQDs to enhance electron transfer kinetics and amplify analytical signals 8,12. A representative architecture involves depositing CQDs, Prussian Blue (PB), and poly(3,4-ethylenedioxythiophene) (PEDOT) as a nanocomposite film onto glassy carbon electrodes via cyclic voltammetry (potential range -0.2 to +1.0 V, scan rate 50 mV/s, 20 cycles) 8. The CQDs/PB/PEDOT-modified electrode exhibits synergistic effects: CQDs provide abundant active sites for biomolecule immobilization, PB catalyzes hydrogen peroxide reduction (peak potential -0.05 V vs. Ag/AgCl), and PEDOT ensures mechanical stability and conductivity 8. When functionalized with acetamiprid-specific aptamers (20 μM, incubation 2 hours at 4°C), this biosensor achieves a detection limit of 6.84 × 10⁻¹⁶ g/mL for acetamiprid via differential pulse voltammetry (DPV), with linear response over 5 orders of magnitude (10⁻¹⁵ to 10⁻¹⁰ g/mL) 8.

The detection mechanism relies on competitive binding: in the absence of acetamiprid, the aptamer-modified electrode surface retains high catalytic activity toward H₂O₂ (added at 5 mM concentration), generating a reduction current of approximately 45 μA at -0.05 V 8. Upon acetamiprid binding, conformational changes in the aptamer reduce the accessibility of PB active sites, decreasing the H₂O₂ reduction current proportionally to acetamiprid concentration 8. This dual-mode detection (DPV peak current and H₂O₂ catalytic current) provides built-in validation and enhances reliability for field applications in pesticide residue monitoring 8. Solid-state quantum dot sensors incorporating CQDs into glucose oxidase enzyme membranes (nitrocellulose matrix, 5 wt% CQDs, 10 U/mg glucose oxidase, crosslinked with 2.5% glutaraldehyde) demonstrate fast response times (<10 seconds) and operational stability exceeding 30 days at 4°C storage 12.

Optical Biosensors Based On Fluorescence Resonance Energy Transfer (FRET)

FRET-based biosensors exploit the spectral overlap between CQD emission and acceptor absorption to transduce molecular recognition events into quantifiable fluorescence changes 11. A carbon dot-based fluorescent sensor for ovarian cancer biomarker HE4 employs CQDs (emission maximum 450 nm, QY 28%) conjugated with HE4-specific aptamers as energy donors, paired with gold nanoclusters (AuNCs, absorption maximum 520 nm) functionalized with complementary DNA (cDNA) as acceptors 11. In the absence of HE4, aptamer-CQD and cDNA-AuNC form a duplex structure with donor-acceptor distance <10 nm, enabling efficient FRET and quenching CQD fluorescence by 75% 11. Upon HE4 binding (concentration range 0.1–100 ng/mL), the aptamer undergoes conformational change, dissociating from cDNA-AuNC and restoring CQD fluorescence proportionally to HE4 concentration 11. This sensor achieves a detection limit of 0.05 ng/mL (approximately 1 pM) with linear response from 0.1 to 50 ng/mL, suitable for early-stage ovarian cancer diagnosis where HE4 levels range from 5 to 150 ng/mL 11.

The synthesis of CQDs for FRET applications requires precise control over emission wavelengths and quantum yields. Hydrothermal treatment of citric acid (1.0 g) and ethylenediamine (0.5 mL) at 180°C for 4 hours produces blue-emitting CQDs (λₑₘ = 440–460 nm, QY 25–30%) with amine-rich surfaces facilitating aptamer conjugation via EDC/NHS coupling chemistry 11. Optimization of donor-acceptor ratios (CQD:AuNC molar ratio 1:2 to 1:5) and incubation conditions (pH 7.4 PBS buffer, 25°C, 1 hour) maximizes FRET efficiency (>70%) while minimizing background fluorescence 11. This biosensor platform is economical (material cost <$5 per 100 assays) and rapid (total assay time <30 minutes), making it suitable for point-of-care diagnostics and on-site screening 11.

Field-Effect Transistor (FET) Biosensors With Quantum Dot Channels

FET-based biosensors integrate CQDs as active channel materials in thin-film transistor architectures, enabling label-free, real-time detection of biomolecular interactions through modulation of channel conductance 2,7. A representative design features a bottom-gate FET structure with a silicon substrate, thermally grown SiO₂ gate dielectric (300 nm thickness, capacitance 11.5 nF/cm²), gold source/drain electrodes (channel length 10 μm, width 1000 μm), and an n-type CQD channel layer (thickness 20–50 nm) deposited via spin-coating (2000 rpm, 60 seconds) 2,7. The CQD layer is functionalized with colloidal quantum dots exhibiting electronic transition energy (1.8–2.2 eV) resonant with vibrational energy of target biomolecules (e.g., glucose C-O stretch at 1080 cm⁻¹ ≈ 0.134 eV) 2,7.

The detection mechanism relies on vibrational energy transfer: when target biomolecules bind to the CQD surface, their molecular vibrations couple with electronic transitions in the quantum dots, generating excitons that dissociate into free carriers under gate bias (Vg = +5 to +20 V), thereby increasing drain current (Id) 2,7. For glucose detection, the biosensor exhibits a linear response from 1 mM to 20 mM (physiological range 4–10 mM), with current changes (ΔId/Id₀) of 5–15% per mM glucose and response time <5 seconds 2,7. The sensor operates at low gate voltages (<10 V) and drain voltages (<1 V), minimizing power consumption (<1 μW) for wearable and implantable applications 7. A charge collection unit comprising a metal-insulator-metal (MIM) capacitor structure (area 100 × 100 μm², capacitance 50 pF) integrated adjacent to the FET channel enhances charge transfer efficiency by 40%, improving signal-to-noise ratio and detection limits 7.

Applications Of Carbon Quantum Dots Biosensors In Clinical Diagnostics And Environmental Monitoring

Cancer Biomarker Detection And Early Diagnosis

CQD-based biosensors demonstrate exceptional performance in detecting cancer-associated biomarkers at clinically relevant concentrations, enabling early diagnosis and treatment monitoring 10,11. A breast cancer biosensor utilizing antibody-conjugated CQDs (anti-CA 15-3 monoclonal antibody, conjugation ratio 5:1 antibody:CQD) detects carbohydrate antigen 15-3 (CA 15-3) in human serum samples via fluorescence quenching upon antigen binding 10. The sensor achieves a detection limit of 0.5 U/mL (clinical cutoff 25 U/mL for breast cancer) with linear range 1–100 U/mL, requiring only 10 μL serum sample and 15-minute incubation time 10. Compared to conventional enzyme-linked immunosorbent assay (ELISA), which requires 3–4 hours and expensive enzyme-conjugated antibodies, the CQD biosensor reduces assay time by 90% and material costs by 70% 10.

The carbon quantum dots are synthesized from natural precursors (e.g., Chenopodium album extract) via hydrothermal carbonization (180°C, 6 hours), yielding green-fluorescent CQDs (λₑₘ = 510–530 nm, QY 18–22%) with excellent water solubility (>50 mg/mL) and low cytotoxicity (cell viability >95% at 200 μg/mL in MCF-7 cells) 18. Surface carboxyl groups (density 2.5 mmol/g, determined by titration) enable covalent antibody conjugation via carbodiimide chemistry (EDC/NHS, molar ratio 1:1:0.5 CQD:EDC:NHS, reaction 2 hours at 25°C) 10. The biosensor exhibits high specificity, with cross-reactivity <5% against other serum proteins (albumin, IgG, transferrin) and maintains stability for 6 months at 4°C storage 10. Clinical validation using 50 breast cancer patient samples and 30 healthy controls demonstrates 92% sensitivity and 88% specificity, comparable to commercial ELISA kits 10.

Heavy Metal Ion Detection In Water And Environmental Samples

CQDs functionalized with metal-chelating groups serve as highly selective fluorescent probes for detecting toxic metal ions (Fe³⁺, Hg²⁺, Pb²⁺, Cd²⁺) in aqueous environments 1,13. A biosensor based on castor leaf-derived CQDs (average size 2.7 nm, QY 12%) exhibits selective fluorescence quenching in the presence of Fe³⁺ ions, with a detection limit of 19 μM and linear response from 20 to 500 μM 1. The quenching mechanism involves coordination of Fe³⁺ with surface hydroxyl and carboxyl groups, forming non-fluorescent Fe-CQD complexes that facilitate non